MAD2L2 and focal segmental glomerulosclerosis: The ATM kinase-MAD2B axis importantly contributes to the cell cycle re-entry of podocytes, representing a novel pathogenic mechanism in FSGS and potentially informing the development of therapeutic strategies for the condition [42].